Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Introduction The role of TOMM40‐APOE 19q13.3 region variants is well documented in Alzheimer's disease (AD) but remains contentious in dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD). Methods We dissected genetic profiles within the TOMM40‐APOE region in 451 individuals from four European brain banks, including DLB and PDD cases with/without neuropathological evidence of AD‐related pathology and healthy controls. Results TOMM40‐L/APOE‐ε4 alleles were associated with DLB (ORTOMM40‐L = 3.61; P value = 3.23 × 10−9; ORAPOE‐ε4 = 3.75; P value = 4.90 × 10−10) and earlier age at onset of DLB (HRTOMM40‐L = 1.33, P value = .031; HRAPOE‐ε4 = 1.46, P value = .004), but not with PDD. The TOMM40‐L/APOE‐ε4 effect was most pronounced in DLB individuals with concomitant AD pathology (ORTOMM40‐L = 4.40, P value = 1.15 × 10−6; ORAPOE‐ε4 = 5.65, P value = 2.97 × 10−8) but was not significant in DLB without AD. Meta‐analyses combining all APOE‐ε4 data in DLB confirmed our findings (ORDLB = 2.93, P value = 3.78 × 10−99; ORDLB+AD = 5.36, P value = 1.56 × 10−47). Discussion APOE‐ε4/TOMM40‐L alleles increase susceptibility and risk of earlier DLB onset, an effect explained by concomitant AD‐related pathology. These findings have important implications in future drug discovery and development efforts in DLB.

Original publication




Journal article


Alzheimer's and Dementia: Translational Research and Clinical Interventions



Publication Date





814 - 824


FFR, neuropathology, APOE, Lewy body dementias, Apolipoprotein E, TOMM40, Parkinson's disease dementia, Parkinson's disease, dementia with Lewy bodies, association analysis, brain banks, Alzheimer's disease